Source: International Congress 2019 – Clinical implications of COPD management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Esmaili (Madrid, Spain), J. Rodriguez Hermosa (Madrid, Spain), A. Fuster Gomila (Madrid, Spain), L. Puente Maestu (Madrid, Spain), C. Amado Diago (Madrid, Spain), F. Callejas González (Madrid, Spain), R. Malo De Molina Ruiz (Madrid, Spain), A. Montero Pacios (Madrid, Spain), M. Calle Rubio (Madrid, Spain). The use of Prevexair application in patients with COPD.. 2700

Member's Comments

No comment yet.

Related content which might interest you: Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Comparison of COPD patients with high and low symptoms from a real-world US survey Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015 Exploration and development of practice with non invasive ventilation (NIV) to patients with chronic obstructive pulmonary disease (COPD) in exacerbation based on the patients, their relatives and healthcare professionals perspectives on treatment Source: Annual Congress 2012 - Nursing led education and follow-up strategies: impact on readmission, self care and patient experiences Year: 2012 QVA149 provides a rapid onset of action which is sustained throughout treatment in patients with COPD Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013 Real-life COPD patients compared to large trial populations: An UNLOCK external validity study Source: Annual Congress 2013 –Management of respiratory diseases in primary care Year: 2013 Indacaterol/glycopyrronium (IND/GLY) reduces exacerbation and improves lung function versus salmeterol/fluticasone (SFC) in patients with and without prior ICS use: The FLAME study Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 Three year follow-up of distribution and stability of patients with COPD according GOLD 2014 Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 A global survey conducted to determine frequency of exacerbations in COPD patients Source: Annual Congress 2013 –COPD treatment Year: 2013 The evaluation of a tele-monitoring model (Teleheath) as an aid in the case management of patients with COPD Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care Year: 2012 An integrated disease management (IDM) programme of 12 months duration was effective for patients with COPD Source: International Congress 2016 – COPD diagnosis and management Year: 2016 QVA149 reduces COPD exacerbation rate in various subgroups of patients: The SPARK study Source: Annual Congress 2013 –New bronchodilators for COPD management Year: 2013 A retrospective cohort study demonstrating the impact of an OPEP device on exacerbations in COPD patients with chronic bronchitis Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Early discharge for patients with exacerbations of COPD - a real life cohort study Source: Annual Congress 2005 - COPD - acute exacerbations Year: 2005 The clinical impact of long-acting bronchodilators in newly diagnosed COPD patients Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013 Comparison of functionality and symptoms in COPD patients with different nutritional status Source: International Congress 2016 – Treatment and assessment of functional outcomes in cardiorespiratory physiotherapy Year: 2016 Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations? Source: Breathe, 15 (4) 353; 10.1183/20734735.0257-2019 Year: 2019 Are current treatment recommendations suited to elderly patients with asthma or COPD? Source: Eur Respir Mon; 2009: 43: 267–285 Year: 2009 Onbrace: A real-life evaluation of indacaterol maintenance treatment for COPD Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 High risk COPD patients cost less if treated according to GOLD 2011 recommendations Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Comparison of modified medical research council scale and COPD assessment test in subjects with COPD Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care Year: 2016